Cite
HARVARD Citation
Jolling, K. et al. (2019). Concentration–QT Modeling Following Inhalation of the Novel Inhaled Phosphodiesterase‐4 Inhibitor CHF6001 in Healthy Volunteers Shows an Absence of QT Prolongation. CPT: pharmacometrics & systems pharmacology. pp. 460-468. [Online].